1 Answers

Daunorubicin in combination with other approved anticancer drugs is indicated for remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults.

Danocin IV Injection সম্পর্কে বিস্তারিত জেনে নিন এই লিঙ্ক থেকে Danocin

4666 views